Stocksigma LogoStocksigma Logo

Zota Health Care Reports Strong Q2FY27 Revenue Growth and Turnaround to Positive EBITDA

Zota Health Care delivered a 54.58% YoY increase in consolidated revenue from operations to ₹19,933.14 lakhs in Q2FY27, driven by a 76.25% YoY rise in

Zota Health Care Reports Strong Q2FY27 Revenue Growth and Turnaround to Positive EBITDA

Zota Health Care Ltd · Investor Presentation · 28 Oct 2026, 11:52 pm

Zota Health Care Reports Strong Q2FY27 Revenue Growth and Turnaround to Positive EBITDA Zota Health Care delivered a 54.58% YoY increase in consolidated revenue from operations to ₹19,933.14 lakhs in Q2FY27, driven by a 76.25% YoY rise in Davaindia sales to ₹16,846.81 lakhs. Consolidated EBITDA turned positive to ₹791.72 lakhs (3.97% margin) from a loss in Q1FY27, though net loss stood at ₹2,596.01 lakhs. Davaindia's network expanded to 2,840 stores (1,859 COCO, 981 FOFO), generating quarterly GMV of ₹18,791 lakhs. Management plans to accelerate store additions in H2FY27 while focusing on cash generation and operational efficiency.

Original exchange filing (PDF)

More announcements from Zota Health Care Ltd

All Zota Health Care Ltd announcements